Close
Nordic 9Nordic 9

Hans and Barbara Bergström Foundation (investor - Others)

United States
See something wrong or missing? Let us know
Offices:Boca Raton
Average round investment:8.4M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Sweden Sigrid Therapeutics
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Hans and Barbara Bergström Foundation

Name Criteria
Ireland Irrus Investments
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Segulah
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Sweden Jonas Sjögren
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Switzerland dRx Capital
71%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States JJDC - Johnson & Johnson
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Robin Tombs
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Ireland Seamus Mulligan
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Cleon Capital
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Acorn Bioventures
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Singapore Hermes-Epitek
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top